Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Long-term Debt
Borrowings due after more than one year.
Shoulder Innovations, Inc.NYSE: SI
Long-term Debt · Q1 FY2026 · quarter ended Mar 2026
Long-term debt broadly unchanged from a year ago
Long-term debt stood at $14.96M at the end of Q1 FY2026, up 1.6% from a year earlier and down 0.0% from the prior quarter.
Context
- Long-term debt amounted to 9.3% of total assets at the end of Q1 FY2026, down 16.3 pp from a year earlier.
- Long-term debt increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether long-term debt keeps rising in the next quarterly balance sheet after a +1.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Debt history
USD · from the balance sheet
- Latest · FY2025
- 14.96M USD
- Year-over-year change
- +2.1%
- 2-year CAGR
- +2.1%
| Period | Period end | Long-term Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 14.96M | +2.1% |
| FY2024 | 2024-12-31 | 14.66M | +2.1% |
| FY2023 | 2023-12-31 | 14.35M | — |
Long-term Debt vs competitors
How SI compares with its peers on the latest reported figures
- SI's Mar 2026 long-term debt of $14.96M is the 6th highest of the 11 companies compared; the peer median is $8.44M.
- Its year-over-year change of +1.6% is the 3rd highest of 4, against a peer median of +3.0%.
- Long-term debt amounts to 9.3% of total assets for SI, versus a peer median of 7.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $98.62M | -22.2% | +329.1% | 31.3% | |
| Mar 2026 | $96.94M | +3.0% | -0.0% | 38.9% | |
| Jun 2026 | $96.41M | +27.4% | +34.4% | 73.0% | |
| Mar 2026 | $25.02M | — | — | 14.1% | |
| Mar 2026 | $14.99M | — | — | 40.4% | |
| Mar 2026 | $14.96M | +1.6% | — | 9.3% | |
| Mar 2026 | $1.9M | — | — | 0.8% | |
EPRXEupraxia Pharmaceuticals Inc. | Mar 2026 | $0 | — | — | 0.0% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Dec 2025 | $0 | — | — | 0.0% | |
| Peer median (excluding SI) | $8.44M | +3.0% | +34.4% | 7.4% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.